Pharma

Pharma Customer & HCP Analytics

Pharma customer analytics breaks when doctor lists, chemist master data, and hospital CRM records use different IDs and refresh cadences. Doctor segmentation pharma becomes political when high-medium-low labels mix gut feel with one quarter of Rx without a stable definition. Chemist performance ranking skews if you rank outlets on raw offtake while ignoring population, competitor stores, and service days. Hospital account profitability hides inside tender discounts, pass-through rebates, and credit days that never meet the same margin logic as retail. Complaint resolution pharma fragments across pharmacovigilance, quality, and medical affairs so product teams see noise, not pattern.

FireAI joins prescription or proxy demand, field activity, outlet attributes, and hospital contract terms where data exists so pharma customer analytics answers which doctors sit in which potential band with evidence, which chemists truly over-index after fair benchmarks, whether hospital account profitability holds after tender and rebate true-up, and whether complaint resolution pharma clusters on batch, region, or channel before escalation.

The domain covers doctor segmentation (high, medium, low), chemist outlet performance ranking, hospital account profitability, and complaint resolution by product, through chat, dashboards, and causal chains commercial and medical leaders can act on in the same review cycle. See how it works: get a demo.

Doctor segmentation (high, medium, low)

Doctor segmentation pharma fails when the CRM tier is a label updated once a year while Rx and competitive share moved last quarter. High-medium-low needs a ruleset medical, sales, and analytics agree on, not a color on a slide.

FireAI blends Rx or proxy volume, growth, specialty fit, and detailing reach where your data allows, then scores doctors into segments with transparent drivers. Doctor segmentation pharma highlights movers between bands, whitespace where coverage lags potential, and accounts where potential is high but call fatigue or access limits ROI.

How FireAI solves the problem: It versions segment definitions with effective dates, attributes changes to Rx, share, or activity shifts, and flags conflicts when the field plan and the data-driven segment disagree.

What FireAI tracks:

  • Segment counts, Rx share, and revenue contribution by band
  • Migration between high, medium, and low with leading indicators
  • Detailing frequency and reach versus segment potential by territory
  • Overlap with key molecules so portfolio teams align medical and sales priorities

MSL and sales leadership use doctor segmentation pharma inside pharma customer analytics to prioritize visits, samples, and digital touchpoints with evidence.

HCP segment pulse

High potential doctors
4,280 2.1%
Medium band share of Rx
38% -0.4%
Segment mismatch flags
312 -18%
Whitespace visits available
1.9K 5%
Doctor segmentation pharma trendRolling quarters, indexed segment Rx
0265177102
Rx share by segment bandCurrent year, cardio focus
HighMediumLowNew

Chemist outlet performance ranking

Chemist performance ranking turns into a raw sales league table unless you normalize for catchment, chain versus independent mix, and service level. Outlets that look weak may be inventory constrained; top outlets may be benefiting from nearby clinic traffic alone.

FireAI ingests outlet attributes, SKU availability signals where present, and secondary or proxy offtake, then ranks chemists on lift versus peer benchmarks and trajectory. Chemist performance ranking exposes true partners for schemes, training, and display investment versus outlets that need supply fixes first.

How FireAI solves the problem: It builds fair peer groups by geography and format, adjusts for stock-out weeks, and separates price-led spikes from sustained share gain.

What FireAI tracks:

  • Rank and percentile within peer group for key brands and packs
  • Velocity trend versus local market proxy or internal benchmark
  • Service and fulfillment proxies when distributor data connects
  • Concentration of growth in top decile outlets for trade spend ROI

Trade marketing and sales use chemist performance ranking with pharma customer analytics to allocate POS, rewards, and van routes where lift is provable.

Ask FireAI about chemist rank

See how your team can ask questions in plain language and get instant analytics answers.

e.g. Which chemists gained share in Pune independents last quarter?

Hospital account profitability

Hospital account profitability collapses when tender price, pass-through rebates, credit days, and return policies sit in different systems than primary billing. A high-volume account can look strategic on top line while margin after true net price is negative.

FireAI ties contract terms, invoice lines, and accruals where data exists, then surfaces contribution after estimated rebates, logistics premiums, and working capital cost. Hospital account profitability highlights accounts where therapy mix, slow pay, or high return rates erode the deal.

How FireAI solves the problem: It maps hospital IDs across CRM and finance, aligns tender SKUs to active contracts, and attributes one-off institutional pulls separately from run-rate ward demand.

What FireAI tracks:

  • Gross to net trajectory by account with tender and rebate bridges
  • Days sales outstanding and working capital drag by hospital group
  • Therapy and SKU mix versus contract assumptions
  • Win-loss on renewals with profitability at stake, not only volume

Key account and finance teams use hospital account profitability inside pharma customer analytics to negotiate renewals and service bundles with numbers both sides trust.

Causal chain: tender drag

Complaint resolution by product

Complaint resolution pharma scatters across quality tickets, medical information logs, and sales escalations. Without product and territory context, teams treat each case as one-off while a batch or pack defect pattern builds.

FireAI normalizes complaint categories, links them to product, batch, region, and channel where identifiers exist, and tracks time to closure with root-cause tags. Complaint resolution pharma surfaces concentration on specific SKUs, geographies, or cold-chain lanes before volume triggers a broader action.

How FireAI solves the problem: It deduplicates repeat reporter noise, joins to shipment and return history when available, and pushes early alerts when rolling rates exceed control limits.

What FireAI tracks:

  • Complaint rate per million units by product and period
  • Median and tail resolution time by category and owner
  • Co-occurrence with temperature, packaging, or labeling themes
  • Link from complaint spikes to chemist or hospital feedback loops

Quality and medical affairs use complaint resolution pharma with pharma customer analytics to prioritize investigations and field communication with aligned facts.

Ask FireAI about complaints

See how your team can ask questions in plain language and get instant analytics answers.

e.g. Which products spiked complaints in the East this month?

Frequently asked questions